Lawsuits pending worldwide
New York City Files Lawsuit Against 44 Drug Makers
New York City officials filed a lawsuit in federal court late Wednesday against 44 drug makers, claiming they overcharged Medicaid for prescription drugs. The suit filed in the Southern District of New York names some of the largest makers of prescription medications, including Aventis Pharmaceuticals Inc., Bristol-Myers Squibb Co., Eli Lilly and Co., Johnson & Johnson, Merck & Co. Inc., Schering-Plough Corp. and Wyeth.
>> Read article at Forbes.com
Pharmaceutical Industry ‘Business With Disease’ Facing Further Legal Challenges
A Judge in the Superior Court of New Jersey in the United States, presiding over a class action lawsuit against the pharmaceutical industry, has approved a master class action complaint form that can be used by all plaintiffs who wish to sue the pharma-cartel.
>> Click here to download a copy in PDF format.
US healthcare fraud convictions up 22%
The number of criminal convictions for healthcare fraud by companies and individuals rose 22 per cent in the US last year amid a crackdown by federal authorities
Bristol-Myers Says It Has Been Subpoenaed
The Bristol-Myers Squibb Company said yesterday that it had received a subpoena from the United States attorney in Boston over pricing and marketing of drugs covered by Medicare and Medicaid.
Pfizer Next In Line
A West Virginia court has ruled that a lawsuit involving Rezulin, a diabetes drug, can proceed as a class action against the world's largest drugmaker, Pfizer, Inc.
AstraZeneca and Medco Charged With Fraud
Crime no longer pays quite as well as it did--or at least, not for health-care firms involved in cheating the American government. On June 20th, AstraZeneca, a British drug firm, agreed to pay $355m to settle federal charges that, among other things, it gave free samples of its cancer drug, Zoladex, to American doctors, to curry favour, knowing that these same doctors were billing the government's Medicare health insurance scheme for unwarranted reimbursement.
Schering-Plough Corporation Facing Federal Charges Over Illegal Drug Marketing Practices
The Schering-Plough Corporation said yesterday (May 30th) that it could soon be indicted in a federal investigation into its prescription drug marketing practices and face charges that employees destroyed documents related to the case. According to the company, prosecutors are examining whether Schering-Plough illegally gave financial grants and other items of value to doctors and other customers, whether it marketed drugs for unapproved uses and whether it submitted false pricing information to the government so that Medicaid paid too much for its products. >> More
Trial Lawyers Are Now Focusing on Lawsuits Against Drug Makers
Enriched and emboldened by the consistent exposure of their business model by this Foundation and after successful fights against asbestos and tobacco companies, some of theUSA's top plaintiffs' lawyers have trained their sights on drug makers, claiming that many giant pharmaceutical companies have hidden the dangers of medicines the lawyers say have harmed thousands of people. >> More
New York State vs GlaxoSmithKline and Pharmacia
On February 13th 2003, exactly eleven days after the publication of Dr Rath's first Open Letter exposing the financial interests behind the pharmaceutical 'business with disease' New York State Attorney General Eliot Spitzer filed complaints in the Supreme Court of the State of New York against GlaxoSmithKline (GSK) and Pharmacia (now part of Pfizer) for making fraudulent and deceptive misrepresentations that conceal the true average wholesale price of its drugs from consumers, Government agencies and drug price reporting services. >> More